# Diffusion Tensor Imaging in the Diagnosis of Perianal Abscess: Protocol for a Single-Blind Randomized Controlled Trial

**Authors:** Yuting Ma, Pingping Mei, Xiutian Guo, Yan Chen

PMC · DOI: 10.2196/83449 · JMIR Research Protocols · 2026-02-25

## TL;DR

This study explores using diffusion tensor imaging (DTI) to improve the diagnosis and treatment of perianal abscesses by providing detailed preoperative assessments.

## Contribution

The study introduces a single-blind randomized controlled trial to evaluate DTI's diagnostic value for perianal abscesses, a novel approach in this field.

## Key findings

- DTI provides detailed visualization of abscess infiltration and pelvic floor structures.
- Structured DTI reports may improve preoperative evaluation and surgical outcomes.
- The trial aims to reduce recurrence rates and improve patient quality of life.

## Abstract

Perianal abscesses are common anorectal conditions that often necessitate surgical intervention. Accurate preoperative assessment is crucial for effective treatment and reducing recurrence rates. Diffusion tensor imaging (DTI) is a valuable method for visualizing the degree of infection and infiltration, the extent of abscess formation, and the relationship between perianal abscess erosion. However, there is currently a lack of specific studies focusing on perianal abscesses.

The objective of this study is to investigate the diagnostic utility of DTI in the preoperative assessment of perianal abscesses. By enhancing the precision of preoperative evaluation, we aim to minimize damage to the anal sphincter, reduce the recurrence rate, and improve the prognosis and quality of life for patients.

This study adopts a randomized, prospective, single-blind design. Ninety participants are being randomized into 2 groups: a DTI group and a conventional magnetic resonance imaging group. A structured report is being completed based on imaging of the perianal abscesses in terms of location, number, specific pus cavity alignment, thickness, and relationship to the surrounding muscles. In addition, the patient condition is being assessed, and corresponding surgical treatment is being performed. If the patient’s blood routine shows infection, cefuroxime sodium combined with metronidazole is being administered intravenously as an anti-infective therapy. Postoperatively, the primary variable is being assessed for recurrence rate at 6 months, and the secondary variables, including postoperative pain scores on days 3 and 7, peripheral blood inflammatory factors, and assessment of anal function, are being evaluated. Normally distributed continuous data will be presented as mean (SD) and analyzed using independent or paired t tests. Non-normally continuous data will be analyzed with rank-sum tests. Categorical data will be expressed as frequency (%) and compared using a chi-square test or appropriate nonparametric tests. Ordinal data will be analyzed using the Ridit test. A P value <.05 will be considered statistically significant.

This study is funded by Science and Technology Commission of Shanghai Municipality Science and Technology Program (grant 23Y11920800). Patient recruitment was initiated in April 2025. As of January 2026, 37 participants have been enrolled, and data collection is scheduled to be completed in October 2026.

DTI technique can be used to gain a deeper understanding of the relationship between internal orifice, the degree of infected infiltration, the extent of the abscess, and the involvement of the perianal tissues and muscles in patients with perianal abscess. Deep pelvic floor DTI reveals the complex 3D structure of the pelvic floor in perianal abscesses through structured reports, which may provide new insights into the diagnosis of perianal abscesses.

## Linked entities

- **Chemicals:** cefuroxime sodium (PubChem CID 23670318), metronidazole (PubChem CID 4173)

## Full-text entities

- **Genes:** IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, IFNA2 (interferon alpha 2) [NCBI Gene 3440] {aka IFN-alpha-2, IFN-alphaA, IFNA, IFNA2B, leIF A}, IL5 (interleukin 5) [NCBI Gene 3567] {aka EDF, IL-5, TRF}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, F2R (coagulation factor II thrombin receptor) [NCBI Gene 2149] {aka CF2R, HTR, PAR-1, PAR1, TR}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}
- **Diseases:** fistula (MESH:D005402), necrotic (MESH:D009336), nephrogenic systemic fibrosis (MESH:D054989), fever (MESH:D005334), anal fistula (MESH:D012003), incontinence (MESH:D014549), infectious diseases (MESH:D003141), motor dysfunction (MESH:D000068079), inflammatory masses (MESH:C536030), bacterial infection (MESH:D001424), language disorders (MESH:D007806), tuberculosis (MESH:D014376), Anal Incontinence (MESH:D001005), lack of appetite (MESH:D001068), Postoperative Pain (MESH:D010149), malignant tumors (MESH:D009369), vertebral malformation (MESH:C535781), chills (MESH:D023341), weakness (MESH:D018908), infected (MESH:D007239), perianal fistula (MESH:D000694), mental disorders (MESH:D001523), renal insufficiency (MESH:D051437), suppurative (MESH:D013492), swelling (MESH:D004487), psychological diseases (MESH:D000067073), Anorectal Diseases (MESH:D012002), birth defect (MESH:D000014), congenital anomaly (MESH:D000013), cardiovascular and cerebrovascular system, nervous system (MESH:D009421), Inflammatory (MESH:D007249), Perianal Abscess (MESH:D000038), diseases of the liver, kidney (MESH:D008107), skin diseases (MESH:D012871), death (MESH:D003643), Pain (MESH:D010146)
- **Chemicals:** alcohol (MESH:D000438), water (MESH:D014867), gadolinium (MESH:D005682), metronidazole (MESH:D008795), iodophor (MESH:D007466), Gadolinium-Diethylenetriamine Pentaacetate (-), GD-DTPA (MESH:D019786), cefuroxime sodium (MESH:D002444)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12935422/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12935422/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC12935422/full.md

---
Source: https://tomesphere.com/paper/PMC12935422